David Gerring
Corporate Officer/Principal en ARECOR THERAPEUTICS PLC .
Fortuna: 264 284 $ al 30/04/2024
Perfil
David Gerring has held positions as Vice President of Development at Arecor Ltd.
and Vice President of Business Development at Arecor Therapeutics Plc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0.50% | 16/11/2022 | 154 626 ( 0.50% ) | 264 284 $ | 30/04/2024 |
Cargos activos de David Gerring
| Empresas | Cargo | Inicio |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- David Gerring
